Form 4 for LFMD LifeMD, Inc.
Accepted 2023-07-13 00:00:00 ET · period of report 2023-07-12 · accession 0001362118-23-000048 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-07-13 | 2023-07-12 | LFMD | Alvarez Nicholas P | Chief Acquisition Off | A - Grant | — | +150.0K | 330.0K | +83% | — |
| D | 2023-07-13 | 2023-07-12 | LFMD | Alvarez Nicholas P | Chief Acquisition Off | D - Sale to Iss | — | -200.0K | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-12 | A | A | 150,000 | — | 330,000 | D | — | — | (F1) The options are being cancelled in exchange for 150,000 restricted shares, with 25,000 vesting on July 12, 2023, 50,000 vesting on January 1, 2024 and 75,000 vesting on January 1, 2025, and performance shares to be reported on settlement. The options vested and became exercisable in equal monthly tranches, based on the passage of time, over the 36 months following December 8, 2020. |
| 2 | Derivative | Employee Stock Option (Right to Buy) | 2023-07-12 | D | D | 200,000 | — | 0 | D | $7.92 · — to — | 200,000 Common Stock | (F1) The options are being cancelled in exchange for 150,000 restricted shares, with 25,000 vesting on July 12, 2023, 50,000 vesting on January 1, 2024 and 75,000 vesting on January 1, 2025, and performance shares to be reported on settlement. The options vested and became exercisable in equal monthly tranches, based on the passage of time, over the 36 months following December 8, 2020. |